Cue Biopharma (CUE) Stock: Buy, Sell, or Hold?
CUE - Cue Biopharma, Inc.
$18.89
-0.06 (-0.32%)
▼
5d:
+1.18%
30d:
-40.43%
90d:
-41.19%
HOLD
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 11, 2026
18d
Get Alerted When CUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CUE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CUE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CUE is currently trading at $18.89, which is considered oversold relative to its 30-day fair value range of $19.60 to $31.79.
Technical Outlook: Technically, CUE is in a downtrend. Immediate support is located at $15.93, while resistance sits at $29.00.
Market Sentiment: CUE scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $88.00 (+365.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CUE is in a downtrend. Immediate support is located at $15.93, while resistance sits at $29.00.
Market Sentiment: CUE scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $88.00 (+365.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.60 -
$31.79
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 365.9% below Wall St target ($88.00)
- CAUTION: Bottoming setup, but lagging the sector by 30% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$19.60 -
$31.79
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$15.93
Resistance Level
$29.00
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.54
Wall Street Target
$88.00
(+365.9%)
Revenue Growth (YoY)
166.7%
Share & Embed Analysis
Last updated: October 23, 2026 4:56 AM ET
Data refreshes hourly during market hours. Next update: 5:56 AM
Data refreshes hourly during market hours. Next update: 5:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
